Haruhi Ando

This inventor holds 21 USPTO granted patents, plus 1 CIPO patent and 6 EPO patents, primarily in Heterocyclic Chemistry. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haruhi Ando. Retrieved from https://idiyas.com/inventor/haruhi-ando

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21

% Patents Active = 95.2

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 52(Granted Patents)

Location History:

Tokyo, JP (2022)
Kanagawa, JP (2014 - 2024)

Company Filing History:

21 out of 1,229

Takeda Pharmaceutical Company Limited

patents

Years Active: 2014-2025

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Neurodegenerative Diseases

Acetylcholine Receptors

Fused Heterocyclic Compounds

1-Arylcarbonyl-4-Oxy-Piperidine

Modulators

Pharmaceuticals

Chemical Synthesis

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12378256 - Heterocyclic compound (2025-08-05),

2. 12162864 - Condensed-cyclic compound (2024-12-10),

3. 12024505 - Heterocyclic compounds useful as modulators of acetylcholine receptors (2024-07-02),

4. 11970483 - Heterocyclic compound (2024-04-30),

5. 11560372 - Heterocyclic compounds useful as modulators of acetylcholine receptors (2023-01-24),

6. 11236099 - Heterocyclic compound (2022-02-01),

7. 11174272 - 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases (2021-11-16),

8. 10717748 - 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases (2020-07-21),

9. 10550129 - 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases (2020-02-04),

10. 10273245 - 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases (2019-04-30),

11. 10144743 - 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases (2018-12-04),

12. 9624184 - Heterocyclic compound (2017-04-18),

13. 9598398 - Heterocyclic compound (2017-03-21),

14. 9586930 - 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases (2017-03-07),

15. 9440990 - 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases (2016-09-13),

Sure, let's prepare an article on inventor Haruhi Ando based on the given data.

Title: Haruhi Ando: Innovating Solutions for Constipation Treatment

Introduction:

Meet Haruhi Ando, a prolific inventor based in Kanagawa, Japan, who has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 17 patents, Ando's work has focused on developing compounds that target conditions such as constipation.

Latest Patents:

Ando's latest patents include breakthroughs in the development of heterocyclic compounds that act as modulators of acetylcholine receptors. These compounds have the potential to revolutionize the prophylaxis and treatment of constipation, offering new hope for patients worldwide.

Career Highlights:

Ando is a valued member of the Takeda Pharmaceutical Company Limited, a renowned pharmaceutical firm known for its commitment to innovation and patient care. His role at Takeda has allowed him to spearhead groundbreaking research in the field of gastrointestinal health.

Collaborations:

In his pursuit of scientific excellence, Ando has collaborated closely with esteemed colleagues such as Masato Yoshikawa and Tatsuki Koike. Together, they have combined their expertise to push the boundaries of pharmaceutical research and development.

Conclusion:

Haruhi Ando's dedication to advancing pharmaceutical science and improving patient outcomes is evident in his extensive patent portfolio. Through his innovative work at Takeda Pharmaceutical Company Limited, Ando continues to make a lasting impact on the field of medicine, particularly in the realm of constipation treatment.

Profile summary based on public USPTO records.